Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling.
Saved in:
| Title: | Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling. |
|---|---|
| Authors: | Tracey, Helen1 (AUTHOR), Bate, Simon T.1,2 (AUTHOR), Ford, Susan2,3 (AUTHOR), Patel, Parul1,3 (AUTHOR), Bloomer, Jackie1,2 (AUTHOR), Patel, Aarti1,3 (AUTHOR), Taskar, Kunal S.1 (AUTHOR) kunal.s.taskar@gsk.com |
| Source: | Pharmaceutics. Apr2025, Vol. 17 Issue 4, p531. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19994923 |
|---|---|
| DOI: | 10.3390/pharmaceutics17040531 |
